Quantum BioPharma (QNTM) Earnings Analysis

Quantum BioPharma (QNTM) next reports earnings on 2026-08-06, consensus EPS -0.4116 USD. Last quarter (2026-05-07) it missed with EPS -3.06 USD vs -0.49038 USD est (-524%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -0.35.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does QNTM next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.4116 USD
Revenue estimaten/a

QNTM earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-3.06 USD-0.49038 USD-524%Miss
2026-03-26-0.71 USD-1.02148 USD+30.5%Beat
2025-11-07-1.25 USD-0.2 USD-525%Miss
2025-05-14-1.41 USD-0.37 USD-281.1%Miss
2024-08-14-5.2 USD-3.9 USD-33.3%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

QNTM valuation and analyst view

Trailing P/E-0.35
Trailing EPS-6.89861 USD
Price / book21.43
Dividend yield0.00%
Market cap0.01B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Quantum BioPharma (QNTM)'s next earnings date?

Quantum BioPharma is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.4116 USD.

Did QNTM beat earnings last quarter?

In its 2026-05-07 report, QNTM posted EPS of -3.06 USD versus a -0.49038 USD estimate — a miss of 524%.

What is QNTM's earnings track record?

Over the last 5 reported quarters with consensus data, QNTM beat estimates 1 times (20%).

What is QNTM's current P/E ratio and EPS?

QNTM trades at a trailing P/E of -0.35 on trailing EPS of -6.898614887861692 USD.

What do analysts rate QNTM?

QNTM has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.